Compounds > lorazepam

lorazepam and amantadine

lorazepam has been researched along with amantadine in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (7.69)	18.7374
1990's	1 (7.69)	18.2507
2000's	7 (53.85)	29.6817
2010's	4 (30.77)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Pike, RF	1
Liepert, J; Schwenkreis, P; Tegenthoff, M; Witscher, K	1
Caroff, SN; Keck, PE; Strawn, JR	1
Babu, K; Brantley, E; Cohn, J	1
Greenway, LL; Kuppuswamy, PS; Lauterbach, EC	1
Dutta, A; Rana, S; Talukdar, A; Talukdar, P	1

Reviews

2 review(s) available for lorazepam and amantadine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Neuroleptic malignant syndrome. The American journal of psychiatry, 2007, Volume: 164, Issue:6 Topics: Adult; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Dantrolene; Diagnosis, Differential; Dopamine; Electroconvulsive Therapy; Female; Humans; Lorazepam; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Risk Factors	2007

Other Studies

11 other study(ies) available for lorazepam and amantadine

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Cocaine withdrawal. An effective three-drug regimen. Postgraduate medicine, 1989, Volume: 85, Issue:4 Topics: Amantadine; Cocaine; Humans; Lorazepam; Substance Withdrawal Syndrome; Substance-Related Disorders; Tryptophan	1989
Pharmacological modulation of training-induced plastic changes in human motor cortex. Electroencephalography and clinical neurophysiology. Supplement, 1999, Volume: 51 Topics: Adult; Amantadine; Differential Threshold; Female; GABA Modulators; Gravitation; Humans; Learning; Lorazepam; Magnetics; Male; Motor Cortex; Neuronal Plasticity; Physical Education and Training; Physical Stimulation; Receptors, N-Methyl-D-Aspartate; Reference Values	1999
Case files of the program in medical toxicology at brown university: amantadine withdrawal and the neuroleptic malignant syndrome. Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2009, Volume: 5, Issue:2 Topics: Amantadine; Antipsychotic Agents; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluid Therapy; Humans; Lorazepam; Middle Aged; Muscle Rigidity; Neuroleptic Malignant Syndrome; Ondansetron; Serotonin Syndrome; Substance Withdrawal Syndrome; Treatment Outcome	2009
Differential pharmacological responses of catatonia-like signs in frontotemporal dementia. Neurocase, 2010, Volume: 16, Issue:5 Topics: Aged; Amantadine; Antipsychotic Agents; Aripiprazole; Benzothiazoles; Catatonia; Citalopram; Clinical Trials as Topic; Dibenzothiazepines; Donepezil; Dopamine Agents; Excitatory Amino Acid Antagonists; Female; Frontotemporal Dementia; Humans; Hypnotics and Sedatives; Indans; Lorazepam; Memantine; Middle Aged; Nootropic Agents; Piperazines; Piperidines; Pramipexole; Quetiapine Fumarate; Quinolones; Selective Serotonin Reuptake Inhibitors	2010
Catatonia and parkinsonism as a sequelae of typhoid fever: a rare experience. BMJ case reports, 2013, Jun-27, Volume: 2013 Topics: Adolescent; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Catatonia; Humans; Hypnotics and Sedatives; Lorazepam; Male; Olanzapine; Parkinsonian Disorders; Pramipexole; Typhoid Fever	2013